Significant differences in EPA content in liver and three adipose tissues depots (Table 2) may also lead to increase of adiponectin secretion in adipose area [57], that could increase the risk of comorbidities of obesity, including cardiovascular disease and insulin resistance [58]. This evidence concerns the gene ADIPOQ and Insulin resistance.